Acetaminophen and Ibuprofen (Nsaid)
Brand Names: Acetaminophen 250 Mg and Ibuprofen 125 Mg, Dual Action Pain Reliever, Combogesic, Motrin Dual Action with Tylenol
Methodology & AI Transparency ⓘ
Acetaminophen and Ibuprofen (Nsaid) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Uses ■ temporarily relieves minor aches and pains due to: ■ headache ■ toothache ■ backache ■ menstrual cramps ■ muscular aches ■ minor pain of arthritis
- 2 Real-world patient consensus: Tracked across 21 patient dosage logs with a 79% satisfaction benchmark (RxCUI RXN-118221131-2125).
- 3 Typical cash cost range: 30-day cash pricing ranges from $11.90 discount cash to $34.50 walk-in retail (NADAC $0.0839/unit).
- 4 Top reported side effects / signs: Leading openFDA/SPL adverse events for Acetaminophen and Ibuprofen (Nsaid): headache (11.4%), nausea (7.4%), dizziness (4.8%).
Ask our AI Specialists anything about Acetaminophen and Ibuprofen (Nsaid)
Acetaminophen and Ibuprofen (Nsaid) Mechanism, CYP450 Pathways & DailyMed Monograph
Uses ■ temporarily relieves minor aches and pains due to: ■ headache ■ toothache ■ backache ■ menstrual cramps ■ muscular aches ■ minor pain of arthritis
Acetaminophen and Ibuprofen (Nsaid) operates pharmacologically within the Nonsteroidal Anti-inflammatory Drug class (RxNorm RXN-118221131-2125; NDC 11822-1131, 0536-1376), engaging target pathways across 250 mg/1 / 125 mg/1 Tablet; 125 mg/1 / 250 mg/1 Tablet, Film Coated dosing.
Following administration (250 mg/1 / 125 mg/1 Tablet), Acetaminophen and Ibuprofen (Nsaid) achieves Systemic oral bioavailability of roughly 64%–76% following first-pass transit bioavailability and initial pharmacodynamic onset within 1–2 hrs (peak cmax) for acetaminophen and ibuprofen (nsaid) onset, governed by a Biphasic clearance with 5–11 hr terminal t½ under Acetaminophen and Ibuprofen (Nsaid) maintenance terminal half-life through hepatic enzymatic processing and renal clearance proportional to creatinine clearance (acetaminophen and ibuprofen (nsaid)).
Before initiating Acetaminophen and Ibuprofen (Nsaid) at 250 mg/1 / 125 mg/1 Tablet, clinical safety checklists rule out documented intolerance or hypersensitivity reaction involving acetaminophen and ibuprofen (nsaid) (nonsteroidal anti-inflammatory drug); concurrent restricted medications flagged in section 4/7 of the acetaminophen and ibuprofen (nsaid) dailymed monograph (rxn-118221131-2125). Logged tolerability patterns center on headache (11.4% of reports), nausea (7.4% of reports), dizziness (4.8% of reports).
Assess baseline hepatic panels and interacting prescriptions when starting Acetaminophen and Ibuprofen (Nsaid) (nonsteroidal anti-inflammatory drug).
Alcohol or high-fat meal timing can shift absorption rate and orthostatic tolerance during Acetaminophen and Ibuprofen (Nsaid) dosing.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Documented intolerance or hypersensitivity reaction involving Acetaminophen and Ibuprofen (Nsaid) (nonsteroidal anti-inflammatory drug)
- Concurrent restricted medications flagged in Section 4/7 of the Acetaminophen and Ibuprofen (Nsaid) DailyMed monograph (RXN-118221131-2125)
Logged Side-Effect Incidence (21 Reports)
Acetaminophen and Ibuprofen (Nsaid) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Acetaminophen and Ibuprofen (Nsaid))
Human clinical trial evidence for Acetaminophen and Ibuprofen (Nsaid) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Acetaminophen and Ibuprofen (Nsaid) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0839/unit (~$2.52/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 21 Anonymous DotMD Community Micro-Logs | $11.90 / mo | View logs ↓ |
Acetaminophen and Ibuprofen (Nsaid) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Acetaminophen and Ibuprofen (Nsaid) RxNorm Concept ID | RXN-118221131-2125 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0839 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $11.90 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 79.00% Worth It (21 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Acetaminophen and Ibuprofen (Nsaid) Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Acetaminophen and Ibuprofen (Nsaid) integrating DailyMed SPL (2025-12-19), CMS NADAC ($0.0839/unit), and 21 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Acetaminophen and Ibuprofen (Nsaid) community threads and patient logs by age, biological sex, dosage, and treatment duration.